XML 14 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUBSEQUENT EVENTS (Details Narrative) (USD $)
1 Months Ended 9 Months Ended 1 Months Ended 9 Months Ended
Jan. 13, 2014
Nov. 30, 2013
Feb. 28, 2013
Nov. 30, 2013
2013 Note Amendments [Member]
Nov. 30, 2013
Additional 2014 Notes [Member]
Jan. 13, 2014
Consultant 2 [Member]
Nov. 30, 2013
Diagnostic Agreement [Member]
Nov. 30, 2013
Therapeutic Agreement [Member]
Payment of license signing fee             $ 15,000 $ 5,000
License fee due in 2015             10,000 10,000
License fee due in 2016             15,000 15,000
License fee due in 2017             25,000 25,000
License fee due in 2018             37,500 37,500
License fee due in 2019 and thereafter             50,000 50,000
Stock options issued 740,000              
Stock option price per share $ 1.50       $ 1.50      
Stock option expiration date Dec. 16, 2023              
Options vest immediately 100,000              
Options future vesting 640,000              
Warrants issued           17,500    
Warrant term           4 years    
Warrant exercise price           $ 2.50    
Aggregate principal amount of Convertible Notes outstanding       1,387,000 700,000      
Convertible note maturity date       Dec. 31, 2013        
Conversion price right       $ 1.50        
Warrants amended       128,700        
Warrant exercise prices   $ 1.77 $ 0.68 $ 2.10 $ 2.10      
New warrant issuances       92,468        
Common stock issued in connection with amendments       92,468 116,667      
Repayment of principal       100,000        
Interest Rate         8.00%      
Gross Proceeds         $ 5,000,000